がん予防財団^® awards nine new research grants

Feb 5, 2021

即時リリース
連絡先: リサ・ベリー・エドワーズ
703-519-2107
Lisa.Edwards@preventcancer.org

Alexandria, VA—The Prevent Cancer Foundation is pleased to announce funding for nine scientists who are researching cancer prevention and early detection. Each scientist is being awarded $100,000 for two years. Areas of focus include the pancreas, esophagus, liver, lungs, skin, prostate, colon-rectum, and blood/bone marrow.

Here are the 2021 research grantees. Click here for more detailed information on their projects.

受給者: Limor Appelbaum, M.D.
命名賞: 素晴らしいゲームをすぐに完成
位置： Staff Scientist
Institution: Beth Israel Deaconess Medical Center, Boston, MA
Project Title: Use of medical records and microbiome for predicting pancreatic cancer

Pancreatic cancer is usually diagnosed in advanced stages when cure is no longer possible. Early detection of this cancer can lead to cure. Dr. Appelbaum proposes a model that can identify people at high risk of pancreatic cancer to be recommended for screening, which can potentially save lives.

受給者: Julie A. Barta, M.D., A.T.S.F.
命名賞: リチャード・C・デヴェロー優秀若手研究者賞
位置： Assistant Professor of Medicine
機関： Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Application Title: Improving lung cancer screening barriers for vulnerable populations

Despite the advent of lung screening to identify cancers at early, curable stages, major disparities exist in screening uptake and adherence. This project will examine and alleviate financial and technological barriers for vulnerable populations to increase lung cancer early detection and survival rates.

受給者: Neil Box, Ph.D.
位置： Associate Professor
Institution: University of Colorado Denver, Anschutz Medical Campus and Denver Campus, Denver, CO
プロジェクト名： Integrating sun damage indicators in melanoma risk modeling

Dr. Box and his team will study how skin damaged by ultraviolet radiation can predict melanoma risk in children of certain genetic makeup. Their work will identify high-risk groups and prove the value of our tools in personalized melanoma prediction and prevention.

受給者: Sigrid Carlsson, M.D., Ph.D., M.P.H.
命名賞: 素晴らしいゲームをすぐに完成
位置： Assistant Attending Epidemiologist
機関： Memorial Sloan Kettering Cancer Center, New York, NY
Application Title: Improving prostate cancer screening using innovative technology

Dr. Carlsson and her team developed an innovative computer technology to help primary care physicians use “smarter” screening for prostate cancer for men who are most likely to benefit. The aim of this study is to test the usefulness of this computerized decision support tool in a large primary care network.

受給者: Margie Clapper, Ph.D.
位置： Deputy Scientific Director/Professor/Co-Leader, Cancer Prevention and Control Program
Institution: The Research Institute of Fox Chase Cancer Center, Philadelphia, PA
プロジェクト名： Impact of atorvastatin with or without aspirin on colorectal biomarkers in patients with Lynch Syndrome: a pilot study

Lynch Syndrome (LS) is the most common genetic cause of colon cancer in people under age 50. Atorvastatin reduces colon microadenomas dramatically in mice. Understanding the effect of atorvastatin with or without aspirin on colon biomarkers is critical to developing a preventive therapy for LS patients.

受給者: William Grady, M.D.
命名賞: シュアファミリー慈善財団
位置： Professor
機関： Fred Hutchinson Cancer Research Center, Seattle, WA
プロジェクト名： Dysbiotic esophageal microbiomes and esophageal cancer risk

These studies have the potential to identify cancer-causing esophageal bacteria, which could lead to novel and improved ways to prevent cancer through more accurate cancer risk prediction. The studies could also lead to novel antibiotic or probiotic cancer prevention treatments for esophageal cancer.

Fellow: Natalia Heredia, Ph.D., M.P.H.
位置： 助教授
機関： The University of Texas Health Science Center, Houston, TX
命名賞: Marcia and Frank Carlucci Charitable Foundation
プロジェクト名： Culturally tailored lifestyle intervention for Hispanic non-alcoholic fatty liver disease

The rate of new cases of liver cancer continues to increase in Hispanics, partially due to a condition called non-alcoholic fatty liver disease (NAFLD). Treatment for NAFLD includes weight loss, so by helping Hispanic NAFLD patients lose weight, we can prevent future cases of NAFLD-related liver cancer.

受給者: Maro Ohanian, D.O.
Named Award: Triad Foundation, LLC
位置： 助教授
Institution: University of Texas M.D. Anderson Cancer Center, Houston, TX
プロジェクト名： Detoxification of environmental metals to prevent acute myeloid leukemia

Toxic metals are a modifiable risk factor associated with increased cancer risk. Dr. Ohanian aims to reverse carcinogenic effects of environmental/occupational metal exposures that can lead to acute myeloid leukemia (AML) by detoxifying metals in patients with myelodysplastic syndrome (pre-leukemia) as a novel cancer prevention method.

Fellow: Aayushi Uberoi, Ph.D.
命名賞: 素晴らしいゲームをすぐに完成
位置： Postdoctoral Scholar
Institution: University of Pennsylvania, Philadelphia, PA
プロジェクト名： Modulating skin microbiota-host interactions to prevent UV-induced skin cancer

While the skin microbiome encounters the same ultraviolet B (UVB) exposure as the skin, the effects of UVB on the skin microbiome is unexplored. By exploring host-microbiome interactions during UVB-associated skin cancers, we can uncover a novel class of biomarkers and therapeutics for prevention of skin cancer.

がん予防財団について^®

がん予防財団^® is celebrating 35 years as the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.

当財団は、2035 年までにがんによる死亡者数を 40% 削減するという課題に立ち向かうべく立ち上がっています。この目標を達成するために、当財団は、がんを早期に発見し、複数のがんのスクリーニングを進めるための革新的な技術に $20 百万ドル、医療サービスが行き届いていないコミュニティへのがんスクリーニングとワクチン接種のアクセス拡大に $10 百万ドル、スクリーニングとワクチン接種の選択肢について一般の人々を啓蒙するために $10 百万ドルを投資することを約束しています。

詳細については、がん予防.